SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-18-046019
Filing Date
2018-07-19
Accepted
2018-07-19 16:02:55
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 a18-17298_1424b5.htm 424B5 476432
2 GRAPHIC g172981aai001.jpg GRAPHIC 6354
3 GRAPHIC g172981bei001.jpg GRAPHIC 6354
4 GRAPHIC g172981hai001.jpg GRAPHIC 6354
5 GRAPHIC g172981aii001.gif GRAPHIC 47196
  Complete submission text file 0001104659-18-046019.txt   569150
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-218638 | Film No.: 18960532
SIC: 2834 Pharmaceutical Preparations